Integrated Investment Consultants Lowers stake in The Advisory Board Company (ABCO)

The Advisory Board Company (ABCO) : Integrated Investment Consultants reduced its stake in The Advisory Board Company by 1.92% during the most recent quarter end. The investment management company now holds a total of 1,535 shares of The Advisory Board Company which is valued at $66,726 after selling 30 shares in The Advisory Board Company , the firm said in a disclosure report filed with the SEC on Oct 14, 2016.The Advisory Board Company makes up approximately 0.03% of Integrated Investment Consultants’s portfolio.

Other Hedge Funds, Including , Msi Financial Services Inc boosted its stake in ABCO in the latest quarter, The investment management firm added 6 additional shares and now holds a total of 116 shares of The Advisory Board Company which is valued at $5,044.Eagle Asset Management Inc reduced its stake in ABCO by selling 19,195 shares or 3.39% in the most recent quarter. The Hedge Fund company now holds 547,684 shares of ABCO which is valued at $23,561,366. The Advisory Board Company makes up approx 0.16% of Eagle Asset Management Inc’s portfolio.Legal General Group Plc reduced its stake in ABCO by selling 861 shares or 7.49% in the most recent quarter. The Hedge Fund company now holds 10,631 shares of ABCO which is valued at $457,346.Bnp Paribas Arbitrage Sa boosted its stake in ABCO in the latest quarter, The investment management firm added 1,809 additional shares and now holds a total of 3,428 shares of The Advisory Board Company which is valued at $145,450.

The Advisory Board Company closed down -0.01 points or -0.02% at $43.47 with 1,43,836 shares getting traded on Friday. Post opening the session at $43.54, the shares hit an intraday low of $43.18 and an intraday high of $44.04 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, The Advisory Board Company reported $0.47 EPS for the quarter, beating the analyst consensus estimate by $ 0.13 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.34. The company had revenue of $198.40 million for the quarter, compared to analysts expectations of $196.49 million. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS.

Many Wall Street Analysts have commented on The Advisory Board Company. The Advisory Board Company was Upgraded by Craig Hallum to ” Buy” on Jul 28, 2016. Company shares were Reiterated by FBR Capital on Jul 28, 2016 to “Mkt Perform”, Firm has raised the Price Target to $ 37 from a previous price target of $35 .The Advisory Board Company was Downgraded by Raymond James to ” Mkt Perform” on Jul 19, 2016.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

Leave a Reply

The Advisory Board Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on The Advisory Board Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.